News
- Author:
- Nancy A. Melville
Publish date: March 2, 2022
The presence and number of iron rim lesions hold a prognostic value for long-term disability in MS.
News
- Author:
- Nancy A. Melville
Publish date: March 2, 2022
This is a potentially important biomarker for disease progression that may otherwise go unrecognized by clinicians and patients.
News
- Author:
- Nancy A. Melville
Publish date: February 25, 2022
New global data show the rate of chronic lymphocytic leukemia increasing in the last 30 years. Is ascertainment bias a factor?
News
- Author:
- Nancy A. Melville
Publish date: February 24, 2022
RFA might be a good option for high risk surgical patients and patients who forgo active surveillance.
News
- Author:
- Nancy A. Melville
Publish date: February 18, 2022
A comprehensive review details the array of immune-mediated inflammatory diseases of the GI tract that look like – but aren’t – IBD.
News
- Author:
- Nancy A. Melville
Publish date: February 11, 2022
Only three therapies are currently approved for treatment of the condition by the FDA – topical minoxidil, oral finasteride, and low-level light th...
News
- Author:
- Nancy A. Melville
Publish date: February 9, 2022
“Our results may help explain a decreasing effectiveness of antibiotic-based therapy in C difficile infection.”
News
- Author:
- Nancy A. Melville
Publish date: February 9, 2022
Survival outcomes are decreased with early, permanent discontinuation of venetoclax but unchanged by treatment interruption, regardless of duration...
News
- Author:
- Nancy A. Melville
Publish date: February 7, 2022
“Our results may help explain a decreasing effectiveness of antibiotic-based therapy in C difficile infection.”
News
- Author:
- Nancy A. Melville
Publish date: February 3, 2022
A decade after CAR T’cell treatment, chronic leukemia patients reported “cured,” with cells still detectable.
News
- Author:
- Nancy A. Melville
Publish date: February 1, 2022
PCV15 and PREVNAR20 received approval from the FDA in July 2021, providing an impetus for the revised recommendations.
News
- Author:
- Nancy A. Melville
Publish date: February 1, 2022
“This is not dissimilar to research with many other nutrients showing that increasing intake above the adequate intake has no further health b...
News
- Author:
- Nancy A. Melville
Publish date: January 26, 2022
Proactive therapeutic drug monitoring over 1 year significantly improves disease control in infliximab treatment of IBDs.
News
- Author:
- Nancy A. Melville
Publish date: January 24, 2022
Probiotic treatment given alongside chemotherapy is sufficient to protect against memory disturbances in patients with breast cancer.
News
- Author:
- Nancy A. Melville
Publish date: January 13, 2022
The procedure can be performed on an outpatient basis in approximately 20 minutes.
